VEGFA and achalasia-alacrima syndrome: Anti-angiogenesis strategies including VEGF-A sequestration/neutralization, VEGF receptor 2 inhibition and alternative angiogenic inhibitors suppress, whereas proangiogenic interventions such as VEGF-A supplementation augmented, experimental AAAs [25,31,39,40,41].